Delivery Order SPE2DB24D8002-SPE2DB25FJMMW
Award Date
10/15/24
Potential Completion Date
10/16/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The $6,172.15 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to the DLA. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $5,203.05, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM, a medication used to treat asthma and COPD. The award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $4,206.61, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4566601984 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM, a respiratory medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 4, 2024....
This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJTJM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov. The award, valued at $3,304.98, is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products. This contract has an ultimate completion date of November 29, 2024, and is a firm fixed-price delivery order contract. Dakota Drug, Inc. is a key supplier for the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The contract, valued at $7,225.70, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM inhalers. The award is associated with a larger Indefinite Delivery Contract (IDC) between Dakota...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,379.65 firm-fixed-price delivery order is for the provision of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,437.20 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. Dakota Drug, Inc. is an established vendor in the federal medical supply market, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJNKB, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov. The contract, valued at $1,129.45, is a delivery order for the supply of FLUTICASONE-SALMETEROL 250-50 60S pharmaceutical products. The contract is not set-aside and has an ultimate completion date of March 26, 2025. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract...
This federal contract award, SPE2DB24D8003|SPE2DB25FJTNP, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products. The award has a ceiling value of $9,501.67 and is a Firm Fixed Price delivery order contract with a period of performance through December 31, 2024. This award is not associated with a set-aside program. Dakota Drug, Inc. is...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $2,538.99, is for the delivery of the pharmaceutical product fluticasone-salmeterol 500-50 60s. This award is associated with Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows...